CX157
CX157 is a selective and reversible [inhibitor of monoamine oxidase A|reversible inhibitor of MAO-A]. As of 2007 it was in phases of [clinical research|phase II] clinical trials for the treatment of depression. In 2013, work on the drug was terminated.